CardioVax Announces Name Change to Abcentra - PRNewswire
CardioVax Announces Name Change to Abcentra PRNewswire
LOS ANGELES, Jan. 30, 2019 /PRNewswire/ -- CardioVax, a privately held, clinical-stage biopharmaceutical company developing novel antibody therapeutics ...
Comments
Post a Comment